Institut de Biotecnologia i de Biomedicina and Departament de Bioquímica i de Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra (Barcelona), Spain.
J Biol Chem. 2012 Mar 16;287(12):9250-8. doi: 10.1074/jbc.M111.330100. Epub 2012 Jan 31.
NvCI is a novel exogenous proteinaceous inhibitor of metallocarboxypeptidases from the marine snail Nerita versicolor. The complex between human carboxypeptidase A4 and NvCI has been crystallized and determined at 1.7 Å resolution. The NvCI structure defines a distinctive protein fold basically composed of a two-stranded antiparallel β-sheet connected by three loops and the inhibitory C-terminal tail and stabilized by three disulfide bridges. NvCI is a tight-binding inhibitor that interacts with the active site of the enzyme in a substrate-like manner. NvCI displays an extended and novel interface with human carboxypeptidase A4, responsible for inhibitory constants in the picomolar range for some members of the M14A subfamily of carboxypeptidases. This makes NvCI the strongest inhibitor reported so far for this family. The structural homology displayed by the C-terminal tails of different carboxypeptidase inhibitors represents a relevant example of convergent evolution.
NvCI 是一种新型的来自海洋蜗牛 Nerita versicolor 的金属羧肽酶外源性蛋白抑制剂。人羧肽酶 A4 与 NvCI 的复合物已被结晶并在 1.7Å 分辨率下确定。NvCI 结构定义了一个独特的蛋白质折叠,基本上由两条反向平行的 β-链通过三个环连接而成,并由三个二硫键稳定。NvCI 是一种紧密结合的抑制剂,以类似于底物的方式与酶的活性位点相互作用。NvCI 与人羧肽酶 A4 呈现出扩展且新颖的界面,对 M14A 亚家族的一些羧肽酶具有皮摩尔级的抑制常数。这使得 NvCI 成为迄今为止该家族报道的最强抑制剂。不同羧肽酶抑制剂的 C 末端尾部显示出的结构同源性代表了趋同进化的一个相关例子。